Literature DB >> 12619740

Case report: prescribing caution. When a simple disease isn't so simple.

Cremona Ticea1, James M Wright.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12619740      PMCID： PMC2214178     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  5 in total

1.  Exacerbation of myasthenia gravis by norfloxacin.

Authors:  E H Rauser; R E Ariano; B A Anderson
Journal:  DICP       Date:  1990-02

Review 2.  Interactions of fluoroquinolones with other drugs: mechanisms, variability, clinical significance, and management.

Authors:  J M Radandt; C R Marchbanks; M N Dudley
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

3.  Norfloxacin-cyclosporine interaction.

Authors:  D J Thomson; A H Menkis; F N McKenzie
Journal:  Transplantation       Date:  1988-08       Impact factor: 4.939

4.  Norfloxacin and cyclosporine--a safe combination.

Authors:  M Jadoul; Y Pirson; C van Ypersele de Strihou
Journal:  Transplantation       Date:  1989-04       Impact factor: 4.939

5.  Drugs that may exacerbate myasthenia gravis.

Authors:  S L Adams; J Mathews; L C Grammer
Journal:  Ann Emerg Med       Date:  1984-07       Impact factor: 5.721
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.